|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Nanosphere, Inc. Announces Exercise of Over-Allotment Option and Closing of Initial Public Offering
11/7/2007 6:33:51 AM
NORTHBROOK, Ill.--(BUSINESS WIRE)--Nanosphere, Inc. (NASDAQ: NSPH), a nanotechnology-based molecular diagnostics company, today announced that the underwriters of Nanosphere’s recent initial public offering of its common stock exercised in full their over-allotment option to purchase an additional 1,050,000 shares of Nanosphere’s common stock at $14.00 per share, less underwriting discounts and commissions. The option was granted in connection with Nanosphere’s initial public offering of 7,000,000 shares. The closing of the sale of all 8,050,000 shares by Nanosphere to the underwriters occurred earlier today.
|
|
|
|
|
|
|
|
|
|
|